Safety and efficacy of liposomal irinotecan as the second-line treatment for advanced pancreatic cancer: A systematic review and meta-analysis
Brian Shiian Chen, Shu‐Yen Chan, Fernand Bteich, Chaoyuan Kuang, Jeffery A. Meyerhardt, Kevin Sheng‐Kai
Topics & Concepts
IrinotecanMeta-analysisPancreatic cancerMedicineCancerOncologyGemcitabineInternal medicineColorectal cancerPancreatic and Hepatic Oncology ResearchCancer therapeutics and mechanismsNanoparticle-Based Drug Delivery